{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T14:49:31Z","timestamp":1719672571816},"reference-count":24,"publisher":"Scientific Scholar","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Dermatol Venereol Leprol"],"published-print":{"date-parts":[[2017]]},"DOI":"10.4103\/ijdvl.ijdvl_625_16","type":"journal-article","created":{"date-parts":[[2017,8,31]],"date-time":"2017-08-31T07:45:35Z","timestamp":1504165535000},"page":"667","source":"Crossref","is-referenced-by-count":2,"title":["Urocytological evaluation of pemphigus patients on long term cyclophosphamide therapy: A cross sectional study"],"prefix":"10.25259","volume":"83","author":[{"given":"Sujay","family":"Khandpur","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saurabh","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saumyaranjan","family":"Mallick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"VinodKumar","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Venkat","family":"Iyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amlesh","family":"Seth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahesh","family":"Kumawat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10894","reference":[{"key":"key-10.4103\/0378-6323.213889-1","first-page":"2045","volume-title":"Cyclophosphamide cystitis \u2013 Identification of acrolein as the causative agent","author":"Cox","year":"1979","journal-title":"Biochem Pharmacol"},{"key":"key-10.4103\/0378-6323.213889-2","first-page":"159","volume-title":"Hemorrhagic cystitis: A challenge to the urologist","author":"Manikandan","year":"2010","journal-title":"Indian J Urol","ISSN":"http:\/\/id.crossref.org\/issn\/0970-1591","issn-type":"print"},{"key":"key-10.4103\/0378-6323.213889-3","first-page":"592","volume-title":"Bladder urotoxicity pathophysiology induced by the oxazaphosphorine alkylating agents and its chemoprevention","author":"Dobrek","year":"2012","journal-title":"Postepy Hig Med Dosw (Online)"},{"key":"key-10.4103\/0378-6323.213889-4","first-page":"9","volume-title":"Incidence and prevention of bladder toxicity from cyclophosphamide in the treatment of rheumatic diseases: A data-driven review","author":"Monach","year":"2010","journal-title":"Arthritis Rheum"},{"key":"key-10.4103\/0378-6323.213889-5","first-page":"477","volume-title":"Cyclophosphamide-induced cystitis and bladder cancer in patients with Wegener granulomatosis","author":"Talar-Williams","year":"1996","journal-title":"Ann Intern Med"},{"key":"key-10.4103\/0378-6323.213889-6","first-page":"1435","volume-title":"Incidence and predictors of urotoxic adverse events in cyclophosphamide-treated patients with systemic necrotizing vasculitides","author":"Le","year":"2011","journal-title":"Arthritis Rheum"},{"key":"key-10.4103\/0378-6323.213889-7","first-page":"309","volume-title":"Urological implications of cyclophosphamide and ifosfamide","author":"Lawson","year":"2008","journal-title":"Scand J Urol Nephrol"},{"key":"key-10.4103\/0378-6323.213889-8","first-page":"1028","volume-title":"Carcinoma of the urinary bladder after treatment with cyclophosphamide for non-Hodgkin's lymphoma","author":"Pedersen-Bjergaard","year":"1988","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0378-6323.213889-9","first-page":"303","volume-title":"Pathophysiological aspects of cyclophosphamide and ifosfamide induced hemorrhagic cystitis; implication of reactive oxygen and nitrogen species as well as PARP activation","author":"Korkmaz","year":"2007","journal-title":"Cell Biol Toxicol"},{"key":"key-10.4103\/0378-6323.213889-10","first-page":"451","volume-title":"Cyclophosphamide-induced hemorrhagic cystitis.A review of 100 patients","author":"Stillwell","year":"1988","journal-title":"Cancer"},{"key":"key-10.4103\/0378-6323.213889-11","first-page":"606","volume-title":"Urological complications of cyclophosphamide","author":"Watson","year":"1973","journal-title":"Br J Urol"},{"key":"key-10.4103\/0378-6323.213889-12","unstructured":"Carless PA. Proposal for the Inclusion of Mesna (Sodium 2-mercaptoethane sulfonate) for the Prevention of Ifosfamide and Cyclophosphamide (oxazaphosphorine cytotoxics) Induced Haemorrhagic Cystitis; 2009. Available from: http:\/\/www.who.int\/selection_medicines\/committees\/expert\/17\/application\/mesna_inclusion.pdf. [Last accessed on 2016 Jan 06]."},{"key":"key-10.4103\/0378-6323.213889-13","first-page":"563","volume-title":"Controlled trial of cyclophosphamide in rheumatoid arthritis","author":"Townes","year":"1976","journal-title":"Arthritis Rheum"},{"key":"key-10.4103\/0378-6323.213889-14","first-page":"1021","volume-title":"An interdisciplinary approach to the care of patients with Wegener's granulomatosis: Long-term outcome in 155 patients","author":"Reinhold-Keller","year":"2000","journal-title":"Arthritis Rheum"},{"key":"key-10.4103\/0378-6323.213889-15","first-page":"397","volume-title":"p53 mutations in cyclophosphamide-associated bladder cancer","author":"Khan","year":"1998","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"key-10.4103\/0378-6323.213889-16","first-page":"100","volume-title":"Malignancies in Wegener's granulomatosis: Incidence and relation to cyclophosphamide therapy in a cohort of 293 patients","author":"Faurschou","year":"2008","journal-title":"J Rheumatol"},{"key":"key-10.4103\/0378-6323.213889-17","first-page":"465","volume-title":", DeRemee RA, McDonald TJ, Weiland LH.Cyclophosphamide-induced bladder toxicity in Wegener's granulomatosis","author":"Stillwell","year":"1988","journal-title":"Arthritis Rheum"},{"key":"key-10.4103\/0378-6323.213889-18","first-page":"412","volume-title":"Urine cytology and adjunct markers for detection and surveillance of bladder cancer","author":"Sullivan","year":"2010","journal-title":"Am J Transl Res"},{"key":"key-10.4103\/0378-6323.213889-19","first-page":"109","volume-title":"Sensitivity and specificity of commonly available bladder tumor markers versus cytology: Results of a comprehensive literature review and meta-analyses","author":"Lotan","year":"2003","journal-title":"Urology"},{"key":"key-10.4103\/0378-6323.213889-20","first-page":"755","volume-title":"Cytokeratin-20 immunocytochemistry in voided urine cytology and its comparison with nuclear matrix protein-22 and urine cytology in the detection of urothelial carcinoma","author":"Srivastava","year":"2012","journal-title":"Diagn Cytopathol"},{"key":"key-10.4103\/0378-6323.213889-21","first-page":"202","volume-title":"Cytokeratin 20 as an immunocytochemical marker for detection of urothelial carcinoma in atypical cytology: Preliminary retrospective study on archived urine slides","author":"Lin","year":"2001","journal-title":"Cancer Detect Prev"},{"key":"key-10.4103\/0378-6323.213889-22","first-page":"659","volume-title":"Evaluation of cyclophosphamide pulse therapy as an adjuvant to oral corticosteroid in the management of pemphigus vulgaris","author":"Sharma","year":"2013","journal-title":"Clin Exp Dermatol"},{"key":"key-10.4103\/0378-6323.213889-23","first-page":"276","volume-title":"Oral cyclophosphamide for treatment of pemphigus vulgaris and foliaceus","author":"Cummins","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0378-6323.213889-24","first-page":"875","volume-title":"Dexamethasone-cyclophosphamide pulse therapy for pemphigus","author":"Pasricha","year":"1995","journal-title":"Int J Dermatol"}],"container-title":["Indian Journal of Dermatology, Venereology and Leprology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T10:45:50Z","timestamp":1611917150000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijdvl.com\/urocytological-evaluation-of-pemphigus-patients-on-long-term-cyclophosphamide-therapy-a-cross-sectional-study\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017]]}},"alternative-id":["213889"],"URL":"https:\/\/doi.org\/10.4103\/ijdvl.ijdvl_625_16","relation":{},"ISSN":["0378-6323"],"issn-type":[{"value":"0378-6323","type":"print"}],"subject":[],"published":{"date-parts":[[2017]]}}}